Zavondemstat

(Synonyms: QC8222 free base; TACH 101 free base)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Zavondemstat (QC8222 free base; TACH 101 free base) is an orally active pan-KDM4 and DHODH inhibitor. Zavondemstat inhibits KDM4A, KDM4B, KDM4C and KDM4D with IC50 values ≤0.080 µM, and exhibits an IC50 of 0.6 nM against human DHODH. Zavondemstat inhibits the KDM4C histone demethylase by competing with the α-ketoglutarate cofactor, and targets DHODH in de novo pyrimidine biosynthesis. Zavondemstat induces apoptosis and S-phase cell cycle arrest, reduces the tumor-initiating cell population, and shows broad antiproliferative activity across multiple cancer cell lines and donor-derived organoids. Zavondemstat can be used for research on colorectal cancer, esophageal squamous cell carcinoma, triple-negative breast cancer and glioblastoma.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : 99.29%
  • CAS. Nr.: 1851412-93-5
  • Formel: C26H29N3O3
  • Molecular Weight:431.53
  • Speicherung:

    4°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Zavondemstat

More

Alle Histone Demethylase Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00